Premenstrual Syndrome and Menstrual Health Supplements Market Share Analysis, Market Growth Forecast, 2021–2032
The Premenstrual Syndrome and Menstrual Health Supplements market is expected to grow from an estimated USD 24.51 billion in 2024 to USD 42.12 billion in 2033, at a CAGR of 6.20%. Premenstrual syndrome (PMS) is characterized by physical and psychological symptoms that occur clinically during the luteal phase of the menstrual cycle and cause substantial anguish and functional impairment. Consumer awareness of female hygiene , as well as rising income levels in developed countries, are some of the factors driving demand for feminine care goods, particularly tampons; sanitary pads and menstrual cups have figured notably in recent years internationally. In addition, authorities from numerous nations are lined up to distribute free sanitary pads. The research report on the Global Premenstrual Syndrome and Menstrual Health Supplements Market is formulated with insightful data that will help the established companies and new entrants to analyze the business trends and capitalize ...